Trinity Biotech Plc

Trinity Biotech Plc is its products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood.

What the company does

• the company sell its products directly in the United States and Brazil and in the United Kingdom, Germany and France and through a network of international distributors and strategic partners in approximately 100 countries worldwide....
• Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
• Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.

Business profile

Trinity Biotech Plc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.